Latest Shareholder Equity News

Page 4 of 13
Everest Metals Corporation has ramped up mining operations at its Mt Dimer Taipan Gold Project, delivering over 25,000 tonnes of ore and initiating a major drilling program to expand resources and optimise production.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.
Ada Torres
Ada Torres
27 Jan 2026
AMCIL Limited has announced a fully franked ordinary dividend of AUD 0.01 per share for the half-year ending December 2025, with options for dividend reinvestment and bonus securities.
Claire Turing
Claire Turing
22 Jan 2026
29Metals has successfully closed its institutional entitlement offer, raising approximately $119 million at a notable discount, with a retail offer set to launch later this month. The capital raise aims to fuel key growth projects across its mining portfolio.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.
Victor Sage
Victor Sage
21 Jan 2026
Finder Energy has completed its acquisition of the Petrojarl I FPSO, issuing over 37 million shares to Amplus Energy as part of the US$15 million deal. Amplus’ Managing Director joins Finder’s board, signalling deeper collaboration.
Maxwell Dee
Maxwell Dee
19 Jan 2026
Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.
Maxwell Dee
Maxwell Dee
16 Jan 2026
London City Equities reveals a strong half-year performance with an 18% rise in investment portfolio values and a favourable legal development involving Excelsior Capital. The company anticipates increased liquidity and is actively seeking new long-term investments.
Claire Turing
Claire Turing
14 Jan 2026
Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.
Ada Torres
Ada Torres
14 Jan 2026
RocketBoots Limited has slightly increased its recent capital raising, issuing an additional 100,000 shares to raise a total of A$7.025 million, reinforcing its push into international markets.
Sophie Babbage
Sophie Babbage
13 Jan 2026
Minbos Resources has obtained a crucial ASX waiver allowing it to issue shares under its Share Purchase Plan without the usual shareholder approval, aligning pricing with its recent Placement and aiming to maintain fairness among investors.
Maxwell Dee
Maxwell Dee
23 Dec 2025
archTIS has renewed 1,000 NC Protect licenses within the U.S. Department of Defense’s Microsoft DoD365 environment and secured an $8 million debt facility to accelerate its U.S. market expansion.
Sophie Babbage
Sophie Babbage
22 Dec 2025